Odonate Therapeutics, Inc. (ODT) financial statements (2021 and earlier)

Company profile

Business Address 3 EAST 28TH STREET
NEW YORK, NY 10016
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments157180139
Cash and cash equivalents157180139
Prepaid expense  1
Other undisclosed current assets33 
Total current assets:160184140
Noncurrent Assets
Operating lease, right-of-use asset42
Property, plant and equipment222
Restricted cash and investments110
Other noncurrent assets111
Total noncurrent assets:853
TOTAL ASSETS:168189143
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities262418
Accounts payable141611
Accrued liabilities1297
Debt 0 
Deferred rent credit  0
Other undisclosed current liabilities1  
Total current liabilities:272518
Noncurrent Liabilities
Long-term debt and lease obligation52 
Operating lease, liability52
Liabilities, other than long-term debt  0
Deferred rent credit  0
Other undisclosed noncurrent liabilities(5)  
Total noncurrent liabilities:520
Total liabilities:322719
Stockholders' equity
Stockholders' equity attributable to parent136162124
Common stock000
Additional paid in capital502402252
Accumulated deficit(366)(240)(128)
Total stockholders' equity:136162124
TOTAL LIABILITIES AND EQUITY:168189143

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Operating expenses(127)(115)(91)
Operating loss:(127)(115)(91)
Nonoperating income
(Other Nonoperating income)
1  
Loss before gain (loss) on sale of properties:(126)(115)(91)
Other undisclosed net income 32
Net loss available to common stockholders, diluted:(126)(112)(89)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Net loss:(126)(112)(89)
Comprehensive loss, net of tax, attributable to parent:(126)(112)(89)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: